Molecular Scalable Solution
A scalable portfolio combining a broad, high-performing assay menu with high-throughput automation. Designed to flexibly scale to meet your needs, from a single patient result to population-level screening.
Information Exclusively Intended for Healthcare Professionals
Simplify and Scale the Future of Diagnostics
Now, more than ever, diagnostic testing holds the key to good health. As pressure and demand increases, consolidation and automation opens new possibilities for future scalability and growth. The Hologic Molecular Solution portfolio allows you to expand your capabilities to simplify, standardise and accelerate quality testing, now and into the future.
Our Team is Here to Help you at Every Step
Strong customer partnerships have been at the heart of our business for over 25 years. We work in close collaboration with you and your team to tailor our innovation to suit your specific needs, today and tomorrow.
Aptima HPV Assay [package insert] AW-22202 Rev. 1. San Diego, CA: Hologic , Inc.; 2023
Aptima Combo 2 Assay. [package insert]. AW-19693-001 Rev. 001. Hologic, Inc., 2020
Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291(11):1368–79.
Adapted from Kent H. Epidemiology of Vaginitis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1168-76
Paladine HL, Desai UM. Vaginitis: Diagnosis and Treatment. Am Fam Physician. 2018;97(5):321-3294
MRSA Assay (Panther Fusion) [Package Insert] AW-22789-001 Rev 001, San Diego, CA; Hologic, Inc., 2023